Pathology Residency Research Opportunities | NYU Langone Health

Skip to Main Content
Pathology Residency Pathology Residency Research Opportunities

Pathology Residency Research Opportunities

Residents in NYU Langone’s Department of Pathology have ample opportunities to pursue research projects. We strongly encourage all trainees to participate and most residents become involved in one or more projects over the course of their training.

For those residents interested in pursuing an academic clinical research career, we offer the anatomic pathology and research track (also known as the physician–scientist pathway), which includes six months of dedicated research time. Upon completion, residents on this track may be accepted into a two- or three-year postdoctoral training program.

We provide dedicated funding for research projects through our Translational Research Program, which is open to all pathology residents and fellows. This program enables trainees to pursue research under the guidance of faculty research mentors. The rate of project approval is high, and those who have strong proposals are likely to be funded. Once projects are selected, residents receive financial, intellectual, and administrative support as they develop their projects and navigate various approval processes.

We also strongly encourage collaboration between clinical and basic researchers throughout the department. We have various active research programs, and host frequent events including Works in Progress talks, biweekly experimental pathology seminars, and an annual Pathology Retreat.

Thanks to the department’s support for resident-led research, our residents are highly productive academically. A large number present at annual meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the College of American Pathologists, and the American Society for Clinical Pathology, as well as many other national and international meetings.

At the 2020 USCAP meeting, eight of our residents presented one or more posters, and four had platform presentations.

Featured Publications

Our residents often publish the results of their innovative research. Learn more about their work by reading the latest papers.

Basu A … Aguero-Rosenfeld ME. Performance of Abbott ID Now COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. J Clin Microbiol. 2020. DOI.

Hindi I … Jour G. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience. Exp Mol Pathol. 2020. DOI.

Occidental M … Jour G. Novel CTNND2-TERT fusion in a spindle cell liposarcoma. Genes Chromosomes Cancer. 2020. DOI.

Saloura V … Nakamura Y. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck. Neoplasia. 2020. DOI.

Vougiouklakis T … Ozerdem U. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions. Pathol Res Pract. 2020. DOI.

Wang L, Allison D, and Shukla PS. Amplification of MDM2 and loss of p16 expression: Do they have a role in malignant transformation of ovarian Brenner tumor? A morphologic and immunohistochemical Study. Am J Clin Pathol. 2020. DOI.

Basu A … Zhou F. First report of bilateral external auditory canal cochlin aggregates (“Cochlinomas”) with multifocal amyloid-like deposits, associated with sensorineural hearing loss and a novel genetic variant in COCH encoding cochlin. Head Neck Pathol. 2019. DOI.

Basu A … Brandler TC. Sarcomatoid carcinoma in cytology: Report of a rare entity presenting in pleural and pericardial fluid preparations. Diagn Cytopathol. 2019. DOI.

Cho M … Simms A. Papillary thyroid carcinoma metastatic to the pancreas: Case report. Diagn Cytopathol. 2019. DOI.

Li F-Q … Raffaniello RD. Chibby is a weak regulator of β-catenin activity in gastric epithelium. J Cell Physiol. 2019. DOI.

Schwartz CJ … Darvishian F. Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma. Hum Pathol. 2019. DOI.